179 related articles for article (PubMed ID: 19169820)
1. New clinical method for distinguishing D-IBS from other gastrointestinal conditions causing diarrhea: the LA/IBS diagnostic strategy.
Pimentel M; Hwang L; Melmed GY; Low K; Vasiliauskas E; Ippoliti A; Yang J; Lezcano S; Conklin JL; Sahakian A
Dig Dis Sci; 2010 Jan; 55(1):145-9. PubMed ID: 19169820
[TBL] [Abstract][Full Text] [Related]
2. The Performance of Nesfatin-1 in Distinguishing Irritable Bowel Syndrome Presenting Predominantly with Diarrhea from Celiac Disease.
Karatay E; Gül-Utku Ö; Aksoy N
Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162872
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
[TBL] [Abstract][Full Text] [Related]
4. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea.
Fine KD; Ogunji F; George J; Niehaus MD; Guerrant RL
Am J Gastroenterol; 1998 Aug; 93(8):1300-5. PubMed ID: 9707055
[TBL] [Abstract][Full Text] [Related]
5. AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Carrasco-Labra A; Lytvyn L; Falck-Ytter Y; Surawicz CM; Chey WD
Gastroenterology; 2019 Sep; 157(3):859-880. PubMed ID: 31351880
[TBL] [Abstract][Full Text] [Related]
6. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
Diederen K; Hoekman DR; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Vlieger AM; Kindermann A; Benninga MA
Aliment Pharmacol Ther; 2016 Jul; 44(2):181-8. PubMed ID: 27110920
[TBL] [Abstract][Full Text] [Related]
8. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
[TBL] [Abstract][Full Text] [Related]
9. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation?
Keohane J; O'Mahony C; O'Mahony L; O'Mahony S; Quigley EM; Shanahan F
Am J Gastroenterol; 2010 Aug; 105(8):1788, 1789-94; quiz 1795. PubMed ID: 20389294
[TBL] [Abstract][Full Text] [Related]
10. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
[TBL] [Abstract][Full Text] [Related]
11. New therapeutic option for irritable bowel syndrome: serum-derived bovine immunoglobulin.
Good L; Rosario R; Panas R
World J Gastroenterol; 2015 Mar; 21(11):3361-6. PubMed ID: 25805945
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission.
Hoekman DR; Zeevenhooven J; D'Haens GR; Benninga MA
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1086-1090. PubMed ID: 28639969
[TBL] [Abstract][Full Text] [Related]
13. Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting.
El-Salhy M; Gilja OH; Hatlebakk JG
Mol Med Rep; 2019 Jul; 20(1):787-794. PubMed ID: 31180516
[TBL] [Abstract][Full Text] [Related]
14. Prodromal irritable bowel syndrome may be responsible for delays in diagnosis in patients presenting with unrecognized Crohn's disease and celiac disease, but not ulcerative colitis.
Barratt SM; Leeds JS; Robinson K; Lobo AJ; McAlindon ME; Sanders DS
Dig Dis Sci; 2011 Nov; 56(11):3270-5. PubMed ID: 21695401
[TBL] [Abstract][Full Text] [Related]
15. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
[TBL] [Abstract][Full Text] [Related]
16. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.
Pimentel M; Morales W; Rezaie A; Marsh E; Lembo A; Mirocha J; Leffler DA; Marsh Z; Weitsman S; Chua KS; Barlow GM; Bortey E; Forbes W; Yu A; Chang C
PLoS One; 2015; 10(5):e0126438. PubMed ID: 25970536
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease, irritable bowel syndrome, or what?: A challenge to the functional-organic dichotomy.
Long MD; Drossman DA
Am J Gastroenterol; 2010 Aug; 105(8):1796-8. PubMed ID: 20686466
[TBL] [Abstract][Full Text] [Related]
19. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.
Weinland SR; Morris CB; Hu Y; Leserman J; Bangdiwala SI; Drossman DA
Am J Gastroenterol; 2011 Oct; 106(10):1813-20. PubMed ID: 21647206
[TBL] [Abstract][Full Text] [Related]
20. Twenty-four-hour manometric study of colonic propulsive activity in patients with diarrhea due to inflammatory (ulcerative colitis) and non-inflammatory (irritable bowel syndrome) conditions.
Bassotti G; de Roberto G; Chistolini F; Sietchiping-Nzepa F; Morelli O; Morelli A
Int J Colorectal Dis; 2004 Sep; 19(5):493-7. PubMed ID: 15083326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
